Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Rating of "Hold" from Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) have earned an average rating of "Hold" from the nine research firms that are presently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $21.56.

A number of analysts have recently issued reports on OSCR shares. Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and cut their price target for the stock from $21.00 to $13.50 in a report on Wednesday, November 6th. Jefferies Financial Group initiated coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 target price on the stock.

Oscar Health Trading Down 0.4 %

NYSE:OSCR traded down $0.07 during trading hours on Thursday, hitting $14.72. The company had a trading volume of 4,028,930 shares, compared to its average volume of 3,870,337. Oscar Health has a 1 year low of $13.05 and a 1 year high of $23.79. The company has a market cap of $3.64 billion, a P/E ratio of -735.38, a P/E/G ratio of 0.50 and a beta of 1.73. The company has a 50-day moving average of $15.09 and a 200 day moving average of $16.84. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Sell-side analysts expect that Oscar Health will post 0.91 earnings per share for the current year.

Insider Activity at Oscar Health

In other Oscar Health news, Director Thrive Partners Vii Growth Gp, acquired 420,819 shares of the company's stock in a transaction that occurred on Tuesday, November 12th. The stock was purchased at an average price of $13.68 per share, for a total transaction of $5,756,803.92. Following the completion of the acquisition, the director now owns 5,452,081 shares of the company's stock, valued at approximately $74,584,468.08. This trade represents a 8.36 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $17.05, for a total transaction of $426,250.00. Following the sale, the director now owns 89,512 shares in the company, valued at approximately $1,526,179.60. This trade represents a 21.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have bought 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Company insiders own 25.11% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of OSCR. KBC Group NV grew its holdings in Oscar Health by 56.1% during the 4th quarter. KBC Group NV now owns 7,107 shares of the company's stock worth $96,000 after acquiring an additional 2,555 shares in the last quarter. ORG Wealth Partners LLC purchased a new stake in shares of Oscar Health during the 4th quarter worth $100,000. Alberta Investment Management Corp acquired a new position in shares of Oscar Health during the fourth quarter worth $138,000. Optimum Investment Advisors purchased a new position in Oscar Health in the third quarter valued at $142,000. Finally, SMART Wealth LLC acquired a new stake in Oscar Health in the fourth quarter valued at $180,000. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.